REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 30 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,000 | -46.2% | 14,300 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $13,000 | -48.0% | 14,300 | 0.0% | 0.01% | -40.0% |
| Q3 2018 | $25,000 | +25.0% | 14,300 | 0.0% | 0.01% | +11.1% |
| Q2 2018 | $20,000 | -9.1% | 14,300 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $22,000 | -24.1% | 14,300 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $29,000 | -17.1% | 14,300 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $35,000 | – | 14,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 0 | $0 | 0.00% |